Loading...
 
Back to the list
Mediterr J Rheumatol 2018;29(3):127-39
Article Links
Dry Eye Disease in Routine Rheumatology Practice
Sevastiani Ziaragkali1, Aggeliki Kotsalidou2, Nikolaos Trakos3
Authors Information

1. Postgraduate Student, Department of Rheumatology, Hygeia Hospital, Athens, Greece

2. Rheumatologist, Department of Rheumatology, Hygeia Hospital, Athens, Greece

3. Ophthalmic Surgeon, Head of Eyelids, Lacrimal & Orbital Department, Hygeia Hospital, Athens, Greece; President of International Society of Dacryology & Dry Eye

Keywords: Dry Eye Disease, Ocular Surface, Sjögren’s Syndrome, Rheumatic Disease
References
  1. Dogru M, Foulks G N, Kinoshita S, Laibson P, McCulley J, Murube J, et al. The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the international dry eye workshop (2007). Ocul Surf 2007;5:75-92. [PMID: 17508116]
  2. Akpek E K, Klimava A, Thorne J E, Martin D, Lekhanont K, Ostrovsky A. Evaluation of patients with dry eye for presence of underlying Sjögren syndrome. Cornea 2009;28(5):493-7. [https://doi.org/10.1097/ICO.0b013e31818d3846] [PMID: 19421051]
  3. Craig J P, Nelson J D, Azar D T, Belmonte C, Bron A J, Chauhan SK, et al. The TFOS DEWS II: Executive Summary. Ocul Surf 2017;15(4):802-12. [https://doi.org/10.1016/j.jtos.2017.08.003]
  4. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop. Ocul Surf 2007;5(2):93-107. [PMID: 17508117]
  5. Galor A, Zheng D D, Arheart K L, et al. Dry eye medication use and expenditures: data from the medical expenditure panel survey 2001 to 2006. Cornea 2012;31(12):1403-7. [https://doi.org/10.1097/ICO.0b013e31823cc0b7] [PMID: 22895158]
  6. Management and therapy of dry eye disease: report of the management and therapy subcommittee of the international dry eye WorkShop. Ocul Surf 2007;5:163-78. [PMID: 17508120]
  7. Wan K H, Chen L J, Young A L. Depression and anxiety in dry eye disease: a systematic review and meta-analysis. Eye (Lond) 2016;30(12):1558-67. [https://doi.org/10.1038/eye.2016.186] [PMID: 27518547]
  8. Stern M E, Beuerman R W, Fox R I, Gao J, Mircheff A K, Pflugfelder S C. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17(6):584-9. [PMID: 9820935]
  9. Bron A J, de Paiva C S, Chauhan S K, Bonini S, Gabison E E, et al. TFOS DEWS II pathophysiology report. Ocul Surf 2017;15(3):438-510. [https://doi.org/10.1016/j.jtos.2017.05.011] [PMID: 28736340]
  10. Taylor S, Pacheco P, Lightman S. Dry Eyes in Rheumatic Disease. Curr Rheumatol Rev 2011;7:3-14.
  11. Pflugfelder S C, Solomon A, Stern M E. The diagnosis and management of dry eye: a twenty-five-year review. Cornea 2000;19(5):644-9. [PMID: 11009316]
  12. Arciniega J C, Nadji E J, Butovich I A. Effects of free fatty acids on Meibomian lipid films. Exp Eye Res 2011;93:452-9. [https://doi.org/10.1016/j.exer.2011.06.007] [PMID: 21718696]
  13. Thompson N, Isenberg D A, Jury E C, Ciurtin C. Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndrome. Rheumatol (Oxford) 2016;55:1548-5. [https://doi.org/10.1093/rheumatology/kev420] [PMID: 26790457]
  14. Rocha E M, Alves M, Rios J D, Dartt D A. The Aging Lacrimal Gland: Changes in Structure and Function. Ocul Surf 2008;6:162-74. [PMID: 18827949]
  15. Battat L, Macri A, Dursun D, Pflugfelder S C. Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface. Ophthalmology 2001;108(7):1230-5. [PMID: 11425680]
  16. Fraunfelder F T, Sciubba J J, Mathers W D. The Role of Medications in Causing Dry Eye. J Ophthalmol 2012;2012:285851. [https://doi.org/10.1155/2012/285851] [PMID: 23050121]
  17. Rischmueller M, Tieu J, Lester S. Primary Sjögren's syndrome. Best Pract Res Clin Rheumatol 2016;30:189-220. [https://doi.org/10.1016/j.berh.2016.04.003] [PMID: 27421224]
  18. Generali E, Costanzo A, Mainetti C, Selmi C. Cutaneous and Mucosal Manifestations of Sjögren’s Syndrome. Clinic Rev Allerg Immunol 2017;53(3):357-70. [https://doi.org/10.1007/s12016-017-8639-y] [PMID: 28871434]
  19. Liu K, Kurien B T, Zimmerman S L, et al. X chromosome dose and sex bias in autoimmune diseases: increased 47,XXX in systemic lupus erythematosus and Sjögren's syndrome. Arthritis Rheumatol 2016;68(5):1290-300. [https://doi.org/10.1002/art.39560] [PMID: 26713507]
  20. Cornec D, Jamin C, Pers J O. Sjögren's syndrome: where do we stand, and where shall we go? J Autoimmun 2014;51:109-14. [https://doi.org/10.1016/j.jaut.2014.02.006] [PMID: 24612946]
  21. Moutsopoulos H M. Sjögren's syndrome: a forty-year scientific journey. J Autoimmun 2014;51:1-9. [https://doi.org/10.1016/j.jaut.2014.01.001] [PMID: 24485155]
  22. Mackay F, Groom J, Tangye S. An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's Syndrome. Curr Opin Rheumatol 2007;19(5):406-13. [https://doi.org/10.1097/BOR.0b013e328277ef4c] [PMID: 17762603]
  23. Brito-Zeron P, Theander E, Baldini C, et al. Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations. Expert Rev Clin Immunol 2015:1-20. [https://doi.org/10.1586/1744666X.2016.1109449] [PMID: 26691952]
  24. Murray P I, Rauz S. The eye and inflammatory rheumatic diseases: The eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis. Best Pract Res Clin Rheumatol 2016;30(5):802-25. [https://doi.org/10.1016/j.berh.2016.10.007] [PMID: 27964790]
  25. Preblea J M, Silpa-archa S, Foster C S. Ocular involvement in systemic lupus erythematosus. Curr Opin Ophthalmol 2015;26:540-5. [https://doi.org/10.1097/ICU.0000000000000209] [PMID: 26367085]
  26. Rentka A, Nagy A, Harsfalvi J, Szucs G, Szekanecz Z, Gesztely R, et al. Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis. Rheumatol Int 2017; 37(11):1835-45. [https://doi.org/10.1007/s00296-017-3794-2] [PMID: 28884335]
  27. Tseng C-C, Chang S-J, Tsai W-C, et al. Sex differential association of dermatomyositis with Sjögren syndrome. CMAJ 2017 February 6;189:E187-93. [https://doi.org/10.1503/cmaj.160783] [PMID: 28246264]
  28. Kocabeyoglu S, Karadag O, Mocan M C, Erden A, Irkec M. Orbital Involvement and Ocular Surface Changes in IgG4-Related Systemic Disease. Cornea 2016;35:1449-53. [https://doi.org/10.1097/ICO.0000000000000965] [PMID: 27467041]
  29. Nebbioso M, Del Regno P, Gharbiya M, Sacchetti M, Plateroti R, Lambiase A. Analysis of the Pathogenic Factors and Management of Dry Eye in Ocular Surface Disorders. Int J Mol Sci 201713;18(8). [https://doi.org/10.3390/ijms18081764] [PMID: 28805710]
  30. Caffery B, Simpson T L, Wang S, et al. Rose bengal staining of the temporal conjunctiva differentiates Sjögren's syndrome from keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 2010;51(5):2381-7. [https://doi.org/10.1167/iovs.09-4188] [PMID: 20107179]
  31. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop. Ocul Surf 2007;5(2):108-52. [PMID: 17508118]
  32. Geerling G, Daniels J T, Dart J K G, et al. Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. Invest Ophthalmol Vis Sci 2001;42:948-56. [PMID: 11274071]
  33. Tong L, Beuerman R, Simonyi S, et al. Effects of punctal occlusion on clinical signs and symptoms and on tear cytokine levels in patients with dry eye. Ocul Surf 2016;14:233e4. [https://doi.org/10.1016/j.jtos.2015.12.004] [PMID: 26774908]
  34. Pullum K W, Whiting M A, Buckley R J. Scleral contact lenses: the expanding role. Cornea 2005;24(3):269-77. [PMID: 15778597]
  35. Rhee M K, Mah F S. Cyclosporine for symptomatic relief in dry eye: a review. Clinical Ophthalmology 2017;11:1157-66. [https://doi.org/10.2147/OPTH.S113437] [PMID: 28790800]